Search - tctmd.com

Displaying 361 - 380 of 426

Sort: Relevancy | Date

Presentation TCT 2012

TCT-24. Combined Near-Infrared Spectroscopic and Intravascular Ultrasound Assessment of Coronary Plaque Burden and Lipid Pools: Validation with Histology

Presenter: Rishi Puri

October 23, 2012

Presentation TCT 2012

TCT-23. Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction

Presenter: Ryan Madder

October 23, 2012

Presentation TCT 2012

TCT-22. Combination of High Wall Shear Stress, Plaque Burden, and Plaque Phenotype has Incremental Value for Prediction of Increased Plaque Vulnerability in Patients with...

Presenter: Michel Corban

October 23, 2012

Presentation TCT 2012

Statement: Molecular Imaging Will Transform the Evaluation of Atherosclerosis

Presenter: Farouc Jaffer

October 23, 2012

Presentation TCT 2012

Should VH-IVUS Be Used as a Clinical Tool to Detect and Treat Vulnerable Plaque TODAY: From PROSPECT to VIVA

Presenter: Patrick Calvert

October 23, 2012

Presentation TCT 2012

Reevaluating the Radiation Risk of CT Angiography

Presenter: Andrew Einstein

October 23, 2012

Presentation TCT 2012

Potential Role for Pan-Vascular Imaging: Insights from the HRP Project

Presenter: Valentin Fuster

October 23, 2012

Presentation TCT 2012

PCSK9 Inhibitors: The Holy Grail?

Presenter: Evan Stein

October 23, 2012

Presentation TCT 2012

Pathogenesis of Vulnerable Plaque 2012: What's New?

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies

Presenter: Shiro Uemura

October 23, 2012

Presentation TCT 2012

NIRS as a Clinical Tool for Vulnerable Plaque Detection: Findings in Patients with Acute STEMI

Presenter: Ryan Madder

October 23, 2012

Presentation TCT 2012

Nanoparticle-based Therapies for Atherosclerosis: The NANOM FIM Study

Presenter: Alexander Kharlamov

October 23, 2012

Presentation TCT 2012

Most Diseases Are Systemic: It's the Focal Manifestations that Count!

Presenter: James Muller

October 23, 2012

Presentation TCT 2012

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Presenter: Bernard De Bruyne

October 23, 2012

Presentation TCT 2012

Introductory Lecture. A New Paradigm Revisited: From Ischemia to Vulnerable Plaque

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

Implications of Low- and High-Shear Stress to Atherosclerosis Progression and Rupture: Predictions Beyond PREDICTION

Presenter: Peter Stone

October 23, 2012

Presentation TCT 2012

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

Presenter: Pedro Moreno

October 23, 2012

Presentation TCT 2012

Darapladib and STABILITY Update

Presenter: Harvey White

October 23, 2012

Presentation TCT 2012

CTA Imaging and Prognosis: From Calcium Scoring to Coronary Anatomy

Presenter: Szilard Voros

October 23, 2012

Presentation TCT 2012

Angioplasty, Atherotomy, and Atherectomy: Mechanisms of Action, Results, and Current Indications

Presenter: Steven Bailey

October 23, 2012

Advertisement

TCT-24. Combined Near-Infrared Spectroscopic and Intravascular Ultrasound Assessment of Coronary Plaque Burden and Lipid Pools: Validation with Histology

TCT-23. Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction

TCT-22. Combination of High Wall Shear Stress, Plaque Burden, and Plaque Phenotype has Incremental Value for Prediction of Increased Plaque Vulnerability in Patients with...

Statement: Molecular Imaging Will Transform the Evaluation of Atherosclerosis

Should VH-IVUS Be Used as a Clinical Tool to Detect and Treat Vulnerable Plaque TODAY: From PROSPECT to VIVA

Reevaluating the Radiation Risk of CT Angiography

Potential Role for Pan-Vascular Imaging: Insights from the HRP Project

PCSK9 Inhibitors: The Holy Grail?

Pathogenesis of Vulnerable Plaque 2012: What's New?

OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies

NIRS as a Clinical Tool for Vulnerable Plaque Detection: Findings in Patients with Acute STEMI

Nanoparticle-based Therapies for Atherosclerosis: The NANOM FIM Study

Most Diseases Are Systemic: It's the Focal Manifestations that Count!

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Introductory Lecture. A New Paradigm Revisited: From Ischemia to Vulnerable Plaque

Implications of Low- and High-Shear Stress to Atherosclerosis Progression and Rupture: Predictions Beyond PREDICTION

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

Darapladib and STABILITY Update

CTA Imaging and Prognosis: From Calcium Scoring to Coronary Anatomy

Angioplasty, Atherotomy, and Atherectomy: Mechanisms of Action, Results, and Current Indications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content